Subcutaneous secukinumab 150mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active as over 4 years

Category Primary study
JournalRheumatology (United Kingdom)
Year 2020
This article has no abstract
Epistemonikos ID: 18a0a3e7a47681f5d44a76a241596c1acbf4f47c
First added on: Feb 12, 2025